Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001946043-25-000002

Chief Commercial Officer bought 16,366 shares at $0.59 ($9,640)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kirkov Kirko Chief Commercial Officer 2025-07-10 Purchase +16,366 $0.59 $9,640 16,366 D
Open-market purchases · 16,366 sh · avg $0.59 · $9,640
Loading xslF345X05/primary_doc.xml…